While distributions of EFS and OS were not significantly different between Regimens A and B for patients with medulloblastoma and sPNET , DI chemotherapy resulted in significantly improved EFS distribution ( P = @ ) ( @-year EFS rates of @ % vs. @ % with SD chemotherapy ) , but not OS distribution , for patients with centrally confirmed ependymoma .